Results 171 to 180 of about 175,275 (261)
Abstract Energy is the basis for socio‐economic development. The effects of fossil‐based energy sources underscore the urgent need for renewable and cost‐effective alternatives. Biofuels derived from non‐edible and low‐cost feedstocks are a promising alternative.
Getachew D. Gebre +3 more
wiley +1 more source
Digital inequalities in the sharing economy: A qualitative text analysis from focus groups. [PDF]
Coy-Mesa D +2 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Infertility and inequality: a plea for action. [PDF]
Li Piani L, Somigliana E.
europepmc +1 more source
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Aims To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.
Valerija Bralić Lang +12 more
wiley +1 more source
Managing health systems under armed conflict: a scoping review of international evidence and a document review of Iranian experiences. [PDF]
Kabiri N +4 more
europepmc +1 more source
Implementation and use of risk minimization control tools in the EU: A multistakeholder survey
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink +21 more
wiley +1 more source

